Arcutis Biotherapeutics, Inc. (ARQT)
收市後：
- Insider Monkey
Zoryve Drives Revenue Growth at Arcutis Biotherapeutics, Inc. (ARQT)
We recently published a list of 10 Best Biotech Stocks To Buy Under $20. In this article, we are going to take a look at where Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) stands against the other best biotech stocks to buy under $20. The biotechnology industry is experiencing rapid growth, driven by increasing demand for innovative treatments, […]
- Insider Monkey
Arcutis Biotherapeutics, Inc. (ARQT): This Small-Cap Healthcare Stock Is A Good Buy Right Now
We recently compiled a list of the 10 Best Small-Cap Healthcare Stocks To Buy Now. In this article, we are going to take a look at where Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) stands against the other small-cap healthcare stocks. Healthcare Sector: A Defensive Investment with Growth Potential in 2024 In difficult economic times, healthcare equities are sometimes […]
- Zacks
Arcutis Biotherapeutics, Inc. (ARQT) Reports Q2 Loss, Misses Revenue Estimates
Arcutis Biotherapeutics (ARQT) delivered earnings and revenue surprises of 12.50% and 0.46%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
